Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Allergan similar filings
- 7 Mar 16 Registration of securities issued in business combination transactions
- 17 Jul 15 Registration of securities issued in business combination transactions
- 26 Jan 15 Registration of securities issued in business combination transactions (amended)
- 23 Dec 14 Registration of securities issued in business combination transactions
- 2 May 14 Registration of securities issued in business combination transactions (amended)
Filing view
External links
Exhibit 23.7
CONSENT OF ERNST & YOUNG LLP,
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF KYTHERA
BIOPHARMACEUTICALS, INC.
We consent to the reference to our firm under the caption “Experts” in the Registration Statement(Form S-4) and related Prospectus of Allergan plc for the registration of its ordinary shares and to the incorporation by reference therein of our report dated March 2, 2015, with respect to the consolidated financial statements of KYTHERA Biopharmaceuticals, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2014, filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP |
Los Angeles, California
July 17, 2015